Freeline to Participate in Upcoming Investor Conferences in April and May 2021

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Reports Full Year 2022 Financial Results and Provides Corporate Update
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher Disease
Freeline to participate in Chardan’s 4th Annual Genetic Medicines Conference at the revised time of 3.45 pm EDT on 6 October
Freeline to Present New Clinical Data for FLT180a in Hemophilia B at International Society on Thrombosis and Haemostasis Congress
Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for Gaucher Disease Type 1
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels